THE SHAPE OF THINGS TO COME: A COHESIVE APPROACH TO PATENT-ELIGIBLE SUBJECT MATTER AND BIOTECHNOLOGY.

The article offers information on the history, scope and significant legal framework for patentable subject matter as applied for patent protection of biotechnology entities under the patent law of the U.S. It discusses the judicial decision of the U.S. Supreme Court in two cases including Mayo Collaborative Services v. Prometheus Labs Inc. and Association for Molecular Pathology v. Myriad Genetics Inc., in which the Court determined the patentable subject matter in biotechnology patent claims.